Global Infectious Disease Therapeutics Market Growth (Status and Outlook) 2024-2030

The global Military Land Vehicles market size was valued at US$ 44520 million in 2023. With growing demand in downstream market, the Military Land Vehicles market is driven by defe

According to our publisher’s latest study, the global Infectious Disease Therapeutics market size was valued at US$ 44730 million in 2023. With growing demand in downstream market, the Infectious Disease Therapeutics is forecast to a readjusted size of US$ 58400 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Infectious Disease Therapeutics market. Infectious Disease Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infectious Disease Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infectious Disease Therapeutics market. Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Key Features: The report on Infectious Disease Therapeutics market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the Infectious Disease Therapeutics market. It may include historical data, market segmentation by Type (e.g., Drugs, Vaccines), and regional breakdowns. Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infectious Disease Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs. Market Drivers: Increasing number of infectious disease cases: The rising incidence of infectious diseases such as HIV, tuberculosis, and malaria, particularly in developing countries, is driving the demand for effective treatments. Advancements in technology: Advances in diagnostic technologies, such as rapid diagnostic tests and molecular diagnostics, are enabling earlier detection and treatment of infectious diseases, which is driving the market growth. Government initiatives: Governments are investing heavily in healthcare infrastructure and initiatives to combat infectious diseases, which is driving the demand for infectious disease therapeutics. Rising awareness: Increasing awareness about the importance of preventive measures and the need for effective treatments is driving the demand for infectious disease therapeutics. Growing geriatric population: The growing geriatric population is increasing the risk of infectious diseases, particularly in developing countries, which is driving the demand for infectious disease therapeutics. Market Challenges: Lack of skilled professionals: The shortage of skilled professionals in the healthcare sector, particularly in developing countries, is hindering the effective diagnosis and treatment of infectious diseases. High cost of treatment: The high cost of treatment for infectious diseases, particularly in developing countries, is a major challenge for patients and healthcare systems. Resistance to antibiotics: The increasing resistance to antibiotics is a major challenge for the treatment of infectious diseases, particularly in developing countries. Lack of access to healthcare: In many developing countries, lack of access to healthcare facilities and healthcare professionals is a major challenge for the diagnosis and treatment of infectious diseases. Government funding: The availability of government funding for healthcare and infectious disease research is a major challenge for the development of new treatments and diagnostic technologies. Competitive Landscape: The research report provides analysis of the competitive landscape within the Infectious Disease Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the Infectious Disease Therapeutics industry. This include advancements in Infectious Disease Therapeutics technology, Infectious Disease Therapeutics new entrants, Infectious Disease Therapeutics new investment, and other innovations that are shaping the future of Infectious Disease Therapeutics. The global infectious disease therapeutics market is witnessing significant technological advancements, driven by the growing need for effective treatments and prevention methods. Some of the key technological developments in the market include: Direct-Acting Antivirals (DAAs): DAAs are a class of antiviral medications that target specific viral proteins, allowing for more effective treatment of viral infections such as HIV and hepatitis. The development of DAAs has revolutionized the treatment of these diseases, offering improved outcomes and reduced side effects. Gene Editing Technologies: Gene editing technologies such as CRISPR-Cas9 have the potential to revolutionize the treatment of infectious diseases by allowing for precise editing of genes to prevent or treat infections. Vaccine Development: Advances in vaccine development have led to the creation of new vaccines for diseases such as Ebola, Zika, and COVID-19. These vaccines have shown promising results in clinical trials and have the potential to save countless lives. Digital Health Technologies: Digital health technologies, such as telemedicine and mobile health applications, are improving access to healthcare services and enabling remote monitoring and treatment of patients with infectious diseases. Artificial Intelligence (AI) and Machine Learning (ML): AI and ML are being used to analyze large amounts of data to identify patterns and predict outbreaks, enabling more effective public health responses. Point-of-Care Diagnostics: Point-of-care diagnostics are allowing for rapid and accurate diagnosis of infectious diseases, enabling timely treatment and reducing the spread of disease. Personalized Medicine: Personalized medicine is becoming increasingly important in the treatment of infectious diseases, with treatments tailored to an individual’s specific genetic profile and medical history. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infectious Disease Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Infectious Disease Therapeutics product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infectious Disease Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infectious Disease Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infectious Disease Therapeutics market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infectious Disease Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infectious Disease Therapeutics market. Recommendations: Development of new treatments: The market is expected to witness the launch of new treatments for various infectious diseases, such as HIV, tuberculosis, and malaria. Pharmaceutical companies should focus on developing innovative treatments that can effectively combat these diseases. Increased investment in research and development: Governments and private organizations should invest in research and development to identify new targets for infectious disease treatment and to develop more effective treatments. Improving access to healthcare: Improving access to healthcare, particularly in developing countries, is crucial to combat infectious diseases. Governments and organizations should work towards increasing access to healthcare facilities and services. Enhancing disease surveillance: Enhancing disease surveillance is essential to detect and respond to outbreaks promptly. Governments and healthcare organizations should invest in disease surveillance systems to track the spread of infectious diseases. Strengthening healthcare infrastructure: Strengthening healthcare infrastructure, including hospitals, clinics, and healthcare workers, is critical to effectively respond to infectious disease outbreaks. Opportunities: Growing demand for antiviral treatments: The demand for antiviral treatments is expected to increase due to the growing prevalence of viral diseases such as HIV, influenza, and hepatitis. Increasing focus on antimicrobial resistance: The growing concern over antimicrobial resistance presents an opportunity for companies to develop new treatments that can combat resistant bacteria and other microorganisms. Growing demand for point-of-care diagnostics: Point-of-care diagnostics are becoming increasingly important in the diagnosis and treatment of infectious diseases. Companies can capitalize on this trend by developing user-friendly and affordable diagnostic tools. Growing demand for vaccines: Vaccines are a crucial tool in preventing infectious diseases. Companies can capitalize on this trend by developing new vaccines and improving existing ones. Growing demand for personalized medicine: Personalized medicine is becoming increasingly important in the treatment of infectious diseases. Companies can capitalize on this trend by developing treatments that are tailored to individual patients. Market Segmentation: Infectious Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Segmentation by type Drugs Vaccines Segmentation by application HIV/AIDS Influenza Hepatitis Malaria Tuberculosis Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Novartis AG Gilead GlaxoSmithKline plc Janssen Pharmaceutical Inc. F. Hoffmann-La Roche Ltd. BioCryst Pharmaceuticals Inc. Merck & Co. Inc. Boehringer Ingelheim GmbH

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Table of Contents

  • 1 Scope of the Report
  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats
  • 2 Executive Summary
  • 2.1 World Market Overview
  • 2.1.1 Global Infectious Disease Therapeutics Market Size 2019-2030
  • 2.1.2 Infectious Disease Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
  • 2.2 Infectious Disease Therapeutics Segment by Type
  • 2.2.1 Drugs
  • 2.2.2 Vaccines
  • 2.3 Infectious Disease Therapeutics Market Size by Type
  • 2.3.1 Infectious Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  • 2.3.2 Global Infectious Disease Therapeutics Market Size Market Share by Type (2019-2024)
  • 2.4 Infectious Disease Therapeutics Segment by Application
  • 2.4.1 HIV/AIDS
  • 2.4.2 Influenza
  • 2.4.3 Hepatitis
  • 2.4.4 Malaria
  • 2.4.5 Tuberculosis
  • 2.4.6 Others
  • 2.5 Infectious Disease Therapeutics Market Size by Application
  • 2.5.1 Infectious Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  • 2.5.2 Global Infectious Disease Therapeutics Market Size Market Share by Application (2019-2024)
  • 3 Infectious Disease Therapeutics Market Size by Player
  • 3.1 Infectious Disease Therapeutics Market Size Market Share by Players
  • 3.1.1 Global Infectious Disease Therapeutics Revenue by Players (2019-2024)
  • 3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2019-2024)
  • 3.2 Global Infectious Disease Therapeutics Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion
  • 4 Infectious Disease Therapeutics by Regions
  • 4.1 Infectious Disease Therapeutics Market Size by Regions (2019-2024)
  • 4.2 Americas Infectious Disease Therapeutics Market Size Growth (2019-2024)
  • 4.3 APAC Infectious Disease Therapeutics Market Size Growth (2019-2024)
  • 4.4 Europe Infectious Disease Therapeutics Market Size Growth (2019-2024)
  • 4.5 Middle East & Africa Infectious Disease Therapeutics Market Size Growth (2019-2024)
  • 5 Americas
  • 5.1 Americas Infectious Disease Therapeutics Market Size by Country (2019-2024)
  • 5.2 Americas Infectious Disease Therapeutics Market Size by Type (2019-2024)
  • 5.3 Americas Infectious Disease Therapeutics Market Size by Application (2019-2024)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil
  • 6 APAC
  • 6.1 APAC Infectious Disease Therapeutics Market Size by Region (2019-2024)
  • 6.2 APAC Infectious Disease Therapeutics Market Size by Type (2019-2024)
  • 6.3 APAC Infectious Disease Therapeutics Market Size by Application (2019-2024)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 7 Europe
  • 7.1 Europe Infectious Disease Therapeutics by Country (2019-2024)
  • 7.2 Europe Infectious Disease Therapeutics Market Size by Type (2019-2024)
  • 7.3 Europe Infectious Disease Therapeutics Market Size by Application (2019-2024)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia
  • 8 Middle East & Africa
  • 8.1 Middle East & Africa Infectious Disease Therapeutics by Region (2019-2024)
  • 8.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2019-2024)
  • 8.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2019-2024)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends
  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends
  • 10 Global Infectious Disease Therapeutics Market Forecast
  • 10.1 Global Infectious Disease Therapeutics Forecast by Regions (2025-2030)
  • 10.1.1 Global Infectious Disease Therapeutics Forecast by Regions (2025-2030)
  • 10.1.2 Americas Infectious Disease Therapeutics Forecast
  • 10.1.3 APAC Infectious Disease Therapeutics Forecast
  • 10.1.4 Europe Infectious Disease Therapeutics Forecast
  • 10.1.5 Middle East & Africa Infectious Disease Therapeutics Forecast
  • 10.2 Americas Infectious Disease Therapeutics Forecast by Country (2025-2030)
  • 10.2.1 United States Infectious Disease Therapeutics Market Forecast
  • 10.2.2 Canada Infectious Disease Therapeutics Market Forecast
  • 10.2.3 Mexico Infectious Disease Therapeutics Market Forecast
  • 10.2.4 Brazil Infectious Disease Therapeutics Market Forecast
  • 10.3 APAC Infectious Disease Therapeutics Forecast by Region (2025-2030)
  • 10.3.1 China Infectious Disease Therapeutics Market Forecast
  • 10.3.2 Japan Infectious Disease Therapeutics Market Forecast
  • 10.3.3 Korea Infectious Disease Therapeutics Market Forecast
  • 10.3.4 Southeast Asia Infectious Disease Therapeutics Market Forecast
  • 10.3.5 India Infectious Disease Therapeutics Market Forecast
  • 10.3.6 Australia Infectious Disease Therapeutics Market Forecast
  • 10.4 Europe Infectious Disease Therapeutics Forecast by Country (2025-2030)
  • 10.4.1 Germany Infectious Disease Therapeutics Market Forecast
  • 10.4.2 France Infectious Disease Therapeutics Market Forecast
  • 10.4.3 UK Infectious Disease Therapeutics Market Forecast
  • 10.4.4 Italy Infectious Disease Therapeutics Market Forecast
  • 10.4.5 Russia Infectious Disease Therapeutics Market Forecast
  • 10.5 Middle East & Africa Infectious Disease Therapeutics Forecast by Region (2025-2030)
  • 10.5.1 Egypt Infectious Disease Therapeutics Market Forecast
  • 10.5.2 South Africa Infectious Disease Therapeutics Market Forecast
  • 10.5.3 Israel Infectious Disease Therapeutics Market Forecast
  • 10.5.4 Turkey Infectious Disease Therapeutics Market Forecast
  • 10.5.5 GCC Countries Infectious Disease Therapeutics Market Forecast
  • 10.6 Global Infectious Disease Therapeutics Forecast by Type (2025-2030)
  • 10.7 Global Infectious Disease Therapeutics Forecast by Application (2025-2030)
  • 11 Key Players Analysis
  • 11.1 Novartis AG
  • 11.1.1 Novartis AG Company Information
  • 11.1.2 Novartis AG Infectious Disease Therapeutics Product Offered
  • 11.1.3 Novartis AG Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.1.4 Novartis AG Main Business Overview
  • 11.1.5 Novartis AG Latest Developments
  • 11.2 Gilead
  • 11.2.1 Gilead Company Information
  • 11.2.2 Gilead Infectious Disease Therapeutics Product Offered
  • 11.2.3 Gilead Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.2.4 Gilead Main Business Overview
  • 11.2.5 Gilead Latest Developments
  • 11.3 GlaxoSmithKline plc
  • 11.3.1 GlaxoSmithKline plc Company Information
  • 11.3.2 GlaxoSmithKline plc Infectious Disease Therapeutics Product Offered
  • 11.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.3.4 GlaxoSmithKline plc Main Business Overview
  • 11.3.5 GlaxoSmithKline plc Latest Developments
  • 11.4 Janssen Pharmaceutical Inc.
  • 11.4.1 Janssen Pharmaceutical Inc. Company Information
  • 11.4.2 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product Offered
  • 11.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.4.4 Janssen Pharmaceutical Inc. Main Business Overview
  • 11.4.5 Janssen Pharmaceutical Inc. Latest Developments
  • 11.5 F. Hoffmann-La Roche Ltd.
  • 11.5.1 F. Hoffmann-La Roche Ltd. Company Information
  • 11.5.2 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product Offered
  • 11.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.5.4 F. Hoffmann-La Roche Ltd. Main Business Overview
  • 11.5.5 F. Hoffmann-La Roche Ltd. Latest Developments
  • 11.6 BioCryst Pharmaceuticals Inc.
  • 11.6.1 BioCryst Pharmaceuticals Inc. Company Information
  • 11.6.2 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product Offered
  • 11.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.6.4 BioCryst Pharmaceuticals Inc. Main Business Overview
  • 11.6.5 BioCryst Pharmaceuticals Inc. Latest Developments
  • 11.7 Merck & Co. Inc.
  • 11.7.1 Merck & Co. Inc. Company Information
  • 11.7.2 Merck & Co. Inc. Infectious Disease Therapeutics Product Offered
  • 11.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.7.4 Merck & Co. Inc. Main Business Overview
  • 11.7.5 Merck & Co. Inc. Latest Developments
  • 11.8 Boehringer Ingelheim GmbH
  • 11.8.1 Boehringer Ingelheim GmbH Company Information
  • 11.8.2 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product Offered
  • 11.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
  • 11.8.4 Boehringer Ingelheim GmbH Main Business Overview
  • 11.8.5 Boehringer Ingelheim GmbH Latest Developments
  • 12 Research Findings and Conclusion

Table 1. Infectious Disease Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Drugs Table 3. Major Players of Vaccines Table 4. Infectious Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 5. Global Infectious Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 6. Global Infectious Disease Therapeutics Market Size Market Share by Type (2019-2024) Table 7. Infectious Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 8. Global Infectious Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 9. Global Infectious Disease Therapeutics Market Size Market Share by Application (2019-2024) Table 10. Global Infectious Disease Therapeutics Revenue by Players (2019-2024) & ($ Millions) Table 11. Global Infectious Disease Therapeutics Revenue Market Share by Player (2019-2024) Table 12. Infectious Disease Therapeutics Key Players Head office and Products Offered Table 13. Infectious Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Infectious Disease Therapeutics Market Size by Regions 2019-2024 & ($ Millions) Table 17. Global Infectious Disease Therapeutics Market Size Market Share by Regions (2019-2024) Table 18. Global Infectious Disease Therapeutics Revenue by Country/Region (2019-2024) & ($ millions) Table 19. Global Infectious Disease Therapeutics Revenue Market Share by Country/Region (2019-2024) Table 20. Americas Infectious Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions) Table 21. Americas Infectious Disease Therapeutics Market Size Market Share by Country (2019-2024) Table 22. Americas Infectious Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 23. Americas Infectious Disease Therapeutics Market Size Market Share by Type (2019-2024) Table 24. Americas Infectious Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 25. Americas Infectious Disease Therapeutics Market Size Market Share by Application (2019-2024) Table 26. APAC Infectious Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions) Table 27. APAC Infectious Disease Therapeutics Market Size Market Share by Region (2019-2024) Table 28. APAC Infectious Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 29. APAC Infectious Disease Therapeutics Market Size Market Share by Type (2019-2024) Table 30. APAC Infectious Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 31. APAC Infectious Disease Therapeutics Market Size Market Share by Application (2019-2024) Table 32. Europe Infectious Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions) Table 33. Europe Infectious Disease Therapeutics Market Size Market Share by Country (2019-2024) Table 34. Europe Infectious Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 35. Europe Infectious Disease Therapeutics Market Size Market Share by Type (2019-2024) Table 36. Europe Infectious Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 37. Europe Infectious Disease Therapeutics Market Size Market Share by Application (2019-2024) Table 38. Middle East & Africa Infectious Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions) Table 39. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Region (2019-2024) Table 40. Middle East & Africa Infectious Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions) Table 41. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Type (2019-2024) Table 42. Middle East & Africa Infectious Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions) Table 43. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Application (2019-2024) Table 44. Key Market Drivers & Growth Opportunities of Infectious Disease Therapeutics Table 45. Key Market Challenges & Risks of Infectious Disease Therapeutics Table 46. Key Industry Trends of Infectious Disease Therapeutics Table 47. Global Infectious Disease Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 48. Global Infectious Disease Therapeutics Market Size Market Share Forecast by Regions (2025-2030) Table 49. Global Infectious Disease Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions) Table 50. Global Infectious Disease Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions) Table 51. Novartis AG Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors Table 52. Novartis AG Infectious Disease Therapeutics Product Offered Table 53. Novartis AG Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 54. Novartis AG Main Business Table 55. Novartis AG Latest Developments Table 56. Gilead Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors Table 57. Gilead Infectious Disease Therapeutics Product Offered Table 58. Gilead Main Business Table 59. Gilead Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Gilead Latest Developments Table 61. GlaxoSmithKline plc Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors Table 62. GlaxoSmithKline plc Infectious Disease Therapeutics Product Offered Table 63. GlaxoSmithKline plc Main Business Table 64. GlaxoSmithKline plc Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 65. GlaxoSmithKline plc Latest Developments Table 66. Janssen Pharmaceutical Inc. Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors Table 67. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product Offered Table 68. Janssen Pharmaceutical Inc. Main Business Table 69. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 70. Janssen Pharmaceutical Inc. Latest Developments Table 71. F. Hoffmann-La Roche Ltd. Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors Table 72. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product Offered Table 73. F. Hoffmann-La Roche Ltd. Main Business Table 74. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 75. F. Hoffmann-La Roche Ltd. Latest Developments Table 76. BioCryst Pharmaceuticals Inc. Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors Table 77. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product Offered Table 78. BioCryst Pharmaceuticals Inc. Main Business Table 79. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 80. BioCryst Pharmaceuticals Inc. Latest Developments Table 81. Merck & Co. Inc. Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors Table 82. Merck & Co. Inc. Infectious Disease Therapeutics Product Offered Table 83. Merck & Co. Inc. Main Business Table 84. Merck & Co. Inc. Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 85. Merck & Co. Inc. Latest Developments Table 86. Boehringer Ingelheim GmbH Details, Company Type, Infectious Disease Therapeutics Area Served and Its Competitors Table 87. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product Offered Table 88. Boehringer Ingelheim GmbH Main Business Table 89. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 90. Boehringer Ingelheim GmbH Latest Developments

Figure 1. Infectious Disease Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Infectious Disease Therapeutics Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Infectious Disease Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Infectious Disease Therapeutics Sales Market Share by Country/Region (2023) Figure 8. Infectious Disease Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Infectious Disease Therapeutics Market Size Market Share by Type in 2023 Figure 10. Infectious Disease Therapeutics in HIV/AIDS Figure 11. Global Infectious Disease Therapeutics Market: HIV/AIDS (2019-2024) & ($ Millions) Figure 12. Infectious Disease Therapeutics in Influenza Figure 13. Global Infectious Disease Therapeutics Market: Influenza (2019-2024) & ($ Millions) Figure 14. Infectious Disease Therapeutics in Hepatitis Figure 15. Global Infectious Disease Therapeutics Market: Hepatitis (2019-2024) & ($ Millions) Figure 16. Infectious Disease Therapeutics in Malaria Figure 17. Global Infectious Disease Therapeutics Market: Malaria (2019-2024) & ($ Millions) Figure 18. Infectious Disease Therapeutics in Tuberculosis Figure 19. Global Infectious Disease Therapeutics Market: Tuberculosis (2019-2024) & ($ Millions) Figure 20. Infectious Disease Therapeutics in Others Figure 21. Global Infectious Disease Therapeutics Market: Others (2019-2024) & ($ Millions) Figure 22. Global Infectious Disease Therapeutics Market Size Market Share by Application in 2023 Figure 23. Global Infectious Disease Therapeutics Revenue Market Share by Player in 2023 Figure 24. Global Infectious Disease Therapeutics Market Size Market Share by Regions (2019-2024) Figure 25. Americas Infectious Disease Therapeutics Market Size 2019-2024 ($ Millions) Figure 26. APAC Infectious Disease Therapeutics Market Size 2019-2024 ($ Millions) Figure 27. Europe Infectious Disease Therapeutics Market Size 2019-2024 ($ Millions) Figure 28. Middle East & Africa Infectious Disease Therapeutics Market Size 2019-2024 ($ Millions) Figure 29. Americas Infectious Disease Therapeutics Value Market Share by Country in 2023 Figure 30. United States Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 31. Canada Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 32. Mexico Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 33. Brazil Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 34. APAC Infectious Disease Therapeutics Market Size Market Share by Region in 2023 Figure 35. APAC Infectious Disease Therapeutics Market Size Market Share by Type in 2023 Figure 36. APAC Infectious Disease Therapeutics Market Size Market Share by Application in 2023 Figure 37. China Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 38. Japan Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 39. Korea Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 40. Southeast Asia Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 41. India Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 42. Australia Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 43. Europe Infectious Disease Therapeutics Market Size Market Share by Country in 2023 Figure 44. Europe Infectious Disease Therapeutics Market Size Market Share by Type (2019-2024) Figure 45. Europe Infectious Disease Therapeutics Market Size Market Share by Application (2019-2024) Figure 46. Germany Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 47. France Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 48. UK Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 49. Italy Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 50. Russia Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 51. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Region (2019-2024) Figure 52. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Type (2019-2024) Figure 53. Middle East & Africa Infectious Disease Therapeutics Market Size Market Share by Application (2019-2024) Figure 54. Egypt Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 55. South Africa Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 56. Israel Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 57. Turkey Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 58. GCC Country Infectious Disease Therapeutics Market Size Growth 2019-2024 ($ Millions) Figure 59. Americas Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 60. APAC Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 61. Europe Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 62. Middle East & Africa Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 63. United States Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 64. Canada Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 65. Mexico Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 66. Brazil Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 67. China Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 68. Japan Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 69. Korea Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 70. Southeast Asia Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 71. India Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 72. Australia Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 73. Germany Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 74. France Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 75. UK Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 76. Italy Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 77. Russia Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 78. Spain Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 79. Egypt Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 80. South Africa Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 81. Israel Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 82. Turkey Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 83. GCC Countries Infectious Disease Therapeutics Market Size 2025-2030 ($ Millions) Figure 84. Global Infectious Disease Therapeutics Market Size Market Share Forecast by Type (2025-2030) Figure 85. Global Infectious Disease Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Logo

Global Infectious Disease Therapeutics Market Growth (Status and Outlook) 2024-2030

Contact usWe are friendly and approachable, give us a call.